Australian (ASX) Stock Market Forum

resapp health

  1. M

    RAP - ResApp Health

    Narhex Life Sciences Limited (ASX: NLS) is an Australian biotechnology company based in Melbourne. Its principal focus is to develop and commercialize its anti-HIV protease inhibitor DG17. DG17 is the water-soluble prodrug of the active anti-HIV drug DG35. When DG17 is administered to animals or...